Skip to main content

Tectonic Therapeutic, Inc.

TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001681087

In the last 90 days, Tectonic Therapeutic, Inc. insiders filed 0 open-market purchases and 2 sales; 115 institutions reported holding it in 13F filings for Q3 2026, worth $332.8M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 18, 2026
$419.7M
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $13.9K in total
2
13F holdersQ3 2026, −6 vs. previous quarter
115
13F valueReported value at the end of Q3 2026
$332.8M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$74.2M
No comparable prior period
Free cash flow, FY2025
-$60.3M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
2.38M
Shares sold short
Change
+151.0K
+6.8% vs. previous
Days to cover
13.66
At average daily volume

Superinvestors holding TECX, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding TECX at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Tectonic Therapeutic, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 2, 2026 (view filing)5:00 PM ETSep 302 daysMcNamara PeterChief Scientific OfficerSSale−536$23.04−$12.3K−1.0%54.3K after10b5-1
Aug 26, 2026 (view filing)4:30 PM ETAug 251 dayMcNamara PeterChief Scientific OfficerSSale−43$36.52−$1.57K−0.1%55.3K after10b5-1
Aug 14, 2026 (view filing)7:25 PM ETAug 122 daysMcNamara PeterChief Scientific OfficerSSale−43$35.00−$1.50K−0.1%55.3K after10b5-1
Jul 1, 2026 (view filing)5:19 PM ETJun 301 dayMcNamara PeterChief Scientific OfficerSSale−172$35.00−$6.02K−0.3%55.3K after10b5-1
May 6, 2026 (view filing)May 42 daysRuddy Marcella K.Chief Medical OfficerSSale−1.06K$30.00−$31.9K−1.5%67.7K after10b5-1
Apr 3, 2026 (view filing)Apr 12 daysRuddy Marcella K.Chief Medical OfficerSSale−1.00K$31.05−$31.1K−1.4%68.7K after10b5-1
Mar 9, 2026 (view filing)Mar 63 daysRuddy Marcella K.Chief Medical OfficerSSale−10.0K$30.00−$300.0K−12.5%69.7K after10b5-1
Mar 9, 2026 (view filing)Mar 63 daysMcNamara PeterChief Scientific OfficerSSale−6.26K$30.17−$188.9K−10.2%55.3K after2 lots10b5-1
Mar 5, 2026 (view filing)Mar 3-42 daysMcNamara PeterChief Scientific OfficerSSale−3.30K$23.53−$77.6K−5.3%58.8K after2 lots10b5-1
Mar 5, 2026 (view filing)Feb 1122 daysReicin AliseChief Executive OfficerPPurchase+2.50K$21.10+$52.8K+2.0%127.0K afterAmended

Top 10 13F holders, Q3 2026

See all 115 holders

The largest institutional positions in Tectonic Therapeutic, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding TECX in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC2,932,368$68.3M0.00%+101,990+3.6%Added
TCG Crossover Management, LLC1,204,891$28.1M0.79%00.0%Unchanged
BlackRock, Inc.860,736$20.0M0.00%−1,856−0.2%Reduced
Baker Bros. Advisors LP607,788$14.2M0.07%00.0%Unchanged
5AM Venture Management, LLC606,660$14.1M4.76%00.0%Unchanged
Vanguard Capital Management LLC512,412$11.9M0.00%+23,607+4.8%Added
First Light Asset Management, LLC495,950$11.6M0.68%−304,776−38.1%Reduced
Standard Life Aberdeen plc484,887$11.3M0.02%−656,937−57.5%Reduced
Marshall Wace, LLP446,511$10.4M0.01%+274,410+159.4%Added
Braidwell LP371,102$8.64M0.36%−225,798−37.8%Reduced

Holders of 5% or more of TECX

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tectonic Therapeutic, Inc..

Largest holders of TECX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Springer Timothy A13D/A31.50%4.31M shares+2.30 ppfrom 29.20%Jun 26, 20245 filingsApr 7, 2025SEC
FMR LLC13G/A15.00%2.80M shares+4.70 ppfrom 10.30%Jul 10, 20244 filingsMay 12, 2025SEC
ADAR1 Partners, LP13G7.40%3.28M sharesNewFeb 23, 20241 filingFeb 23, 2024SEC
McGuire Terrance13D/A6.30%658.0K shares0.00 ppfrom 6.30%Jun 25, 20243 filingsApr 7, 2025SEC
TCG Crossover GP II, LLC13G6.20%1.17M sharesNewFeb 27, 20261 filingFeb 27, 2026SEC